Clinical trial
Efficacy, Safety and Satisfaction of the New Pen Needle 33G x 4 mm 33G x 4 mm: Cross-over Randomized Controlled Clinical Trial. Studio AGO 01
NCT01745549 is registered in ClinicalTrials.gov with Consorzio Mario Negri Sud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Safety and Satisfaction of the New Pen Needle 33G x 4 mm 33G x 4 mm: Cross-over Randomized Controlled Clinical Trial. Studio AGO 01
- Lead sponsor
- Consorzio Mario Negri Sud
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- November 30, 2013
- Enrollment
- 87 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes, type 2 diabetes